HormoneInvestigational

GHRP-6

Subcutaneous injection, Intravenous

Overview

A synthetic hexapeptide growth hormone secretagogue that stimulates the anterior pituitary via GHS-R1a receptor activation. GHRP-6 produces significant GH release and also potently stimulates appetite through ghrelin-mimetic activity in hypothalamic feeding centers.

Mechanism of Action

It increases gastric motility and has cytoprotective effects on gastric and cardiac tissue through NO-mediated pathways..

Research Summary & Key Findings

Robust GH-releasing activity confirmed in multiple clinical studies with dose-dependent responses. Notable appetite-stimulating effect limits its use in weight management contexts. Research in Cuba demonstrated cardioprotective and gastroprotective effects. Synergistic with CJC-1295 and other GHRH analogs for enhanced GH pulsatility.

Clinical Status

Investigational

GHRP-6 is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injectionIntravenous

Related Peptides in Hormone

Find a Provider

Find a verified provider who offers GHRP-6 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply GHRP-6.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.